Amgen Prepares Cholesterol Drug for U.S. Review After Late Study

... may tip the scales in the company's favor. Regeneron plans to file for approval in the U.S. in 2015, the Tarrytown, New York-based drugmaker told investors earlier this month at the JPMorgan Chase & Co. health-care conference. Pfizer Inc., Roche ...

http://ift.tt/1dcrZzJ